
Results
27
Mid-Large Cap Stocks
27 companies
PharmaResearch
Market Cap: ₩4.1t
Operates as a biopharmaceutical company primarily in South Korea.
A214450
₩393,000.00
7D
-5.8%
1Y
-41.8%
Yuhan
Market Cap: ₩5.9t
Operates as a pharmaceutical company in South Korea and internationally.
A000100
₩79,600.00
7D
-7.0%
1Y
-30.1%
Samsung BiologicsLtd
Market Cap: ₩70.8t
Together with its subsidiaries engages in the manufacturing, commercializing, distributing, and selling of biopharmaceuticals products in South Korea, Europe, the United States, and internationally.
A207940
₩1,531,000.00
7D
-4.8%
1Y
-2.8%
Hanall Biopharma
Market Cap: ₩3.0t
A pharmaceutical company, manufactures and sells pharmaceutical products in South Korea and internationally.
A009420
₩58,700.00
7D
3.2%
1Y
101.7%
Samsung Epis Holdings
Market Cap: ₩9.5t
A biotechnology company, manage the portfolio of biopharmaceutical products.
A0126Z0
₩384,500.00
7D
-9.8%
1Y
n/a
D&D Pharmatech
Market Cap: ₩2.6t
Engages in the research and development and manufacturing of pharmaceuticals in South Korea.
A347850
₩57,800.00
7D
-5.1%
1Y
69.5%
SK bioscienceLtd
Market Cap: ₩2.9t
Engages in the research and development, production, and distribution of vaccines and biopharmaceuticals in Korea and internationally.
A302440
₩36,500.00
7D
-2.7%
1Y
-23.9%
L&C BIOLTD
Market Cap: ₩1.4t
Operates as a research and development company in tissue regeneration medicine.
A290650
₩52,800.00
7D
-16.9%
1Y
70.9%
NatureCellLtd
Market Cap: ₩1.5t
Engages in manufacturing and selling of canned and health functional food products, beverages, stem cell, and cosmetics in South Korea.
A007390
₩22,600.00
7D
-3.4%
1Y
13.6%
Peptron
Market Cap: ₩4.2t
Engages in the development of peptide-based medicines.
A087010
₩180,000.00
7D
-2.4%
1Y
-40.2%
Hanmi Pharm
Market Cap: ₩5.0t
A biopharmaceutical company, engages in the manufacture and sale of pharmaceutical products in South Korea, China, Japan, the United States, and internationally.
A128940
₩392,000.00
7D
-5.1%
1Y
38.0%
Hugel
Market Cap: ₩2.7t
Develops and manufactures biopharmaceuticals in South Korea and internationally.
A145020
₩248,000.00
7D
-12.2%
1Y
-19.3%
ALTEOGEN
Market Cap: ₩20.8t
A bio company, focuses on developing long-acting biobetters, proprietary antibody-drug conjugates, and antibody biosimilars.
A196170
₩298,000.00
7D
-9.0%
1Y
-9.3%
Celltrion Pharm
Market Cap: ₩1.9t
A pharmaceutical company, develops and sells biosimilars and over-the-counter drugs in South Korea.
A068760
₩41,900.00
7D
-9.1%
1Y
-19.5%
SK Biopharmaceuticals
Market Cap: ₩6.7t
A pharmaceutical company, engages in the research, development, and commercialization of drugs for the treatment of central nervous system disorders.
A326030
₩85,200.00
7D
-5.9%
1Y
-12.8%
ABL Bio
Market Cap: ₩4.5t
A biotech research company, focuses on the development of therapeutic drugs for immuno-oncology and neurodegenerative diseases.
A298380
₩79,800.00
7D
-10.4%
1Y
-4.0%
Mezzion PharmaLtd
Market Cap: ₩2.0t
Develops, manufactures, and sells pharmaceutical products in South Korea.
A140410
₩64,600.00
7D
2.5%
1Y
77.0%
ST PharmLtd
Market Cap: ₩2.1t
Provides manufacturing services for active pharmaceutical ingredient and intermediate.
A237690
₩100,300.00
7D
-7.1%
1Y
12.2%
Aimed Bio
Market Cap: ₩1.7t
Develops therapeutic solutions for patients with brain diseases, including neuro-oncological and degenerative diseases.
A0009K0
₩25,800.00
7D
-3.7%
1Y
n/a
Sam Chun Dang Pharm
Market Cap: ₩4.3t
Engages in the manufacturing and sale of pharmaceutical products in South Korea.
A000250
₩184,700.00
7D
-3.7%
1Y
4.3%
Caregen
Market Cap: ₩2.7t
A biotechnology company, researches, develops, and commercializes biomimetic peptides worldwide.
A214370
₩55,400.00
7D
-16.1%
1Y
18.6%
Kolon TissueGene
Market Cap: ₩2.3t
Develops cell therapies for orthopedic diseases and other unmet medical needs.
A950160
₩27,600.00
7D
40.7%
1Y
-25.2%
Celltrion
Market Cap: ₩44.8t
A biopharmaceutical company, engages in the development, production, and sale of development, production, and sale of medicinal products.
A068270
₩195,500.00
7D
-7.1%
1Y
18.7%
LigaChem Biosciences
Market Cap: ₩3.9t
A clinical stage biopharmaceutical company, engages in the discovery and development of medicines for unmet medical needs.
A141080
₩105,100.00
7D
-10.1%
1Y
-28.4%
OliX Pharmaceuticals
Market Cap: ₩2.2t
A clinical stage pharmaceutical company, focuses on developing RNA interference (RNAi) therapeutics for dermal, ophthalmic, and pulmonary diseases.
A226950
₩106,500.00
7D
-19.3%
1Y
87.2%
Voronoi
Market Cap: ₩3.1t
Researches, develops, and discovers small molecule kinase inhibitors in South Korea.
A310210
₩174,500.00
7D
-1.1%
1Y
52.0%
Orum Therapeutics
Market Cap: ₩1.4t
A biopharmaceutical company, engages in the research and development of pharmaceuticals for cancer and immune diseases in South Korea and the United States.
A475830
₩65,700.00
7D
-7.5%
1Y
180.2%